We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$223M
AUM Growth
-$41.4M
Cap. Flow
-$38.1M
Cap. Flow %
-17.06%
Top 10 Hldgs %
11%
Holding
420
New
44
Increased
50
Reduced
231
Closed
47

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$2.06M
2
PBR icon
Petrobras
PBR
+$2M
3
VALE icon
Vale
VALE
+$1.96M
4
CQP icon
Cheniere Energy
CQP
+$1.94M
5
STR
Sitio Royalties
STR
+$1.94M

Top Sells

Rank Stock Value
1
BCC icon
Boise Cascade
BCC
+$2.62M
2
EXR icon
Extra Space Storage
EXR
+$2.49M
3
CNQ icon
Canadian Natural Resources
CNQ
+$2.46M
4
IMO icon
Imperial Oil
IMO
+$2.45M
5
AVNT icon
Avient
AVNT
+$2.42M

Sector Composition

Rank Sector Weight
1 Materials 20.16%
2 Real Estate 20.02%
3 Healthcare 16.51%
4 Energy 10.55%
5 Utilities 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYTM icon
201
Rhythm Pharmaceuticals
RYTM
$7.41B
$188K 0.08%
16,317
-973
-6% -$8.54K
XENE icon
202
Xenon Pharmaceuticals
XENE
$6.28B
$186K 0.08%
6,078
-361
-6% -$10.8K
RXDX
203
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$185K 0.08%
4,889
-282
-5% -$11.1K
CERE
204
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$183K 0.08%
5,216
-309
-6% -$9.02K
ISEE
205
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$181K 0.08%
10,729
-631
-6% -$9.33K
STOK icon
206
Stoke Therapeutics
STOK
$1.83B
$180K 0.08%
8,559
-511
-6% -$10.2K
RETA
207
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$176K 0.08%
5,364
-320
-6% -$9.5K
KROS icon
208
Keros Therapeutics
KROS
$199M
$175K 0.08%
3,225
-191
-6% -$9.8K
KALV
209
DELISTED
KalVista Pharmaceuticals
KALV
$174K 0.08%
11,784
-698
-6% -$10K
KRTX
210
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$173K 0.08%
1,367
-84
-6% -$9.46K
KDNY
211
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$172K 0.08%
10,536
-622
-6% -$8.46K
RLAY icon
212
Relay Therapeutics
RLAY
$3.99B
$166K 0.07%
5,558
-327
-6% -$7.93K
GERN icon
213
Geron
GERN
$930M
$165K 0.07%
121,143
-7,182
-6% -$8.01K
IMGO
214
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$165K 0.07%
8,560
-505
-6% -$10.5K
RVMD icon
215
Revolution Medicines
RVMD
$39.1B
$163K 0.07%
6,375
-371
-5% -$8.07K
BTAI icon
216
BioXcel Therapeutics
BTAI
$26.1M
$161K 0.07%
482
-28
-5% -$8.12K
RGNX icon
217
Regenxbio
RGNX
$615M
$160K 0.07%
4,830
-282
-6% -$7.83K
ARVN icon
218
Arvinas
ARVN
$529M
$158K 0.07%
2,348
-146
-6% -$9.95K
NKTR icon
219
Nektar Therapeutics
NKTR
$2.39B
$158K 0.07%
1,956
– –
TVRD
220
Tvardi Therapeutics
TVRD
$22.9M
$157K 0.07%
359
-22
-6% -$9.03K
LONA
221
LeonaBio Inc
LONA
$65.5M
$156K 0.07%
1,156
-69
-6% -$7.28K
IMCR icon
222
Immunocore
IMCR
$1.7B
$156K 0.07%
5,216
-307
-6% -$7.75K
BTX
223
BlackRock Technology and Private Equity Term Trust
BTX
$919M
$155K 0.07%
13,601
+8,389
+161% +$106K
CYTK icon
224
Cytokinetics
CYTK
$10.8B
$154K 0.07%
4,176
-249
-6% -$8.85K
IBRX icon
225
ImmunityBio
IBRX
$7.3B
$153K 0.07%
27,343
-1,626
-6% -$9.98K
7 8
9
10 11

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, Virtus ETF Advisers held 420 positions worth $223M, down 16% from $265M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Virtus ETF Advisers withdrew a net $38.1M in Q1 2022, closing 47 positions and reducing 231 holdings. Its most notable exit was Boise Cascade, an estimated $2.62M position sold in full.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 14% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Virtus ETF Advisers opened a new position in The Mosaic Company worth $2.75M.

  • Virtus ETF Advisers's largest Q1 2022 buy was The Mosaic Company: 41,283 shares worth $2.75M.
  • Virtus ETF Advisers added most to Agnico Eagle Mines in Q1 2022, an estimated $1.28M increase.
  • Virtus ETF Advisers's biggest Q1 2022 reduction was Gold Fields, cutting an estimated $1.09M.
  • Virtus ETF Advisers fully exited Boise Cascade in Q1 2022, selling an estimated $2.62M.
  • Virtus ETF Advisers's ten largest holdings make up 11% of its $223M portfolio in Q1 2022.
  • Virtus ETF Advisers opened 44 new positions and closed 47 in Q1 2022.
  • Virtus ETF Advisers's portfolio value fell 16% quarter-over-quarter to $223M.

Based on Virtus ETF Advisers's 13F filing for Q1 2022, filed 16 May 2022.